Cue Biopharma (CUE) had the highest return on April 10 by a micro-cap US stock, returning 68.1%.

ASSET	DATE	% RETURN
Cue Biopharma (CUE)	4/10/2026	68.14%
Zentalis Pharmaceuticals Llc (ZNTL)	4/10/2026	46.24%
Solo Brands (SBDS)	4/10/2026	44.04%
U Power Limited Ordinary Shares (UCAR)	4/10/2026	29.44%
Faraday Future Intelligent Electric (FFAI)	4/10/2026	27.92%
Tempest Therapeutics (TPST)	4/10/2026	25.77%
Beasley Broadcast (BBGI)	4/10/2026	23.92%
Heritage Distilling (IPST)	4/10/2026	23.78%
Zenta (ZTG)	4/10/2026	23.2%
Sidus Space (SIDU)	4/10/2026	23.19%
XCF Global, Inc Class A Common Stock (SAFX)	4/10/2026	22.56%
CCSC Technology International Holdings Limited Ordinary Shares (CCTG)	4/10/2026	20.59%
Aprea Therapeutics (APRE)	4/10/2026	20.5%
BeLive Holdings Ordinary Share (BLIV)	4/10/2026	19.5%
Treace Medical Concepts (TMCI)	4/10/2026	19.08%
CN Energy (CNEY)	4/10/2026	19%
Quince Therapeutics (QNCX)	4/10/2026	18.26%
IRulya Therapeutics (IRLA)	4/10/2026	18.26%
Optical Cable (OCC)	4/10/2026	18.19%
Cibus Global LLC (CBUS)	4/10/2026	17.97%
YYForce (YFOR)	4/10/2026	16.94%
Nexalin Technology (NXL)	4/10/2026	16.52%
TuHURA Biosciences (HURA)	4/10/2026	16.41%
NewcelX (NCEL)	4/10/2026	16.36%
Cerenome (CNSY)	4/10/2026	15.94%

Micro-cap stocks are treated as having a market cap of <= $300M.